Otto is a US-based veterinary workflow platform that enhances clinic operations, automates administrative tasks, and improves client engagement, ultimately…
Otto is a US-based veterinary workflow platform that enhances clinic operations, automates administrative tasks, and improves client engagement, ultimately streamlining the veterinary practice experience for professionals and pet owners alike.Otto, founded in 2015, is a veterinary technology company focused on improving operational efficiency within veterinary clinics. The company is headquartered in Austin, US. The CEO is Steven Carter, who has a background in leading technology initiatives. Otto has raised a total of USD 32.47 mn in Series B funding on May 8, 2023, with key investments from Boehringer Ingelheim Venture, Hill's Pet Nutrition, Inc., and Mercury, achieving a current company valuation of USD 124.28 mn.Otto provides a veterinary workflow platform that streamlines clinic operations, enhances client engagement, and automates administrative tasks. Its services include an integrated suite of tools for communication between veterinary clinics and pet owners, payment processing, and care plan management. The platform is designed to reduce routine task times by up to 66% and minimize no-show rates by 50%. Additionally, it features an AI Suite for generating SOAP notes and appointment documentation, serving over 10,000 veterinary professionals across the US and Canada.Otto's revenue model is primarily subscription-based, allowing veterinary practices to access its comprehensive services. Clients benefit from flexible payment options that can save clinics an average of USD 840 per month. The platform fosters long-term partnerships with veterinary clinics, providing key services such as automated workflows and integrated payment solutions, which play a significant role in revenue generation.Following the recent Series B funding of USD 32.47 mn in May 2023, Otto plans to expand its product offerings and enhance its platform's features. The company is looking to enter new markets across North America, specifically targeting additional geographic regions by the end of 2024. The funding will support the development of upcoming tools designed to further automate veterinary workflows and improve overall clinic efficiency.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in